Patents Assigned to Viacell, Inc.
  • Methods for improving central nervous system functioning
    Patent number: 7811557
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 12, 2010
    Assignees: Viacell, Inc., The General Hospital Corp.
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark
  • Use of human cord blood-derived pluripotent cells for the treatment of disease
    Publication number: 20090181087
    Abstract: The present invention features methods of organ tissue regeneration using pluripotent cells derived from umbilical cord blood, compositions of these pluripotent cells, methods for further transforming these cells, and uses for these transformed cells.
    Type: Application
    Filed: December 20, 2004
    Publication date: July 16, 2009
    Applicant: Viacell, Inc.
    Inventors: Morey Kraus, Marc D. Beer, Paul T. Clark
  • TREATMENT OF MUSCULAR DYSTROPHY WITH CORD BLOOD CELLS
    Publication number: 20090068156
    Abstract: The invention features methods for treating a patient suffering from muscular dystrophy by administration of umbilical cord blood cells, e.g., by IV infusion.
    Type: Application
    Filed: November 18, 2008
    Publication date: March 12, 2009
    Applicant: Viacell, inc.
    Inventors: Robert H. Brown, JR., Seth P. Finklestein, Morey Kraus
  • Treatment of muscular dystrophy with cord blood cells
    Patent number: 7452529
    Abstract: The invention features methods for treating a patient suffering from muscular dystrophy by administration of umbilical cord blood cells, e.g., by IV infusion.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: November 18, 2008
    Assignees: Viacell, Inc., The General Hospital Corporation
    Inventors: Robert H. Brown, Jr., Seth P. Finklestein, Morey Kraus
  • Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
    Patent number: 6866843
    Abstract: Methods and compositions are described for the treatment of type I insulin-dependent diabetes mellitus and other conditions using newly identified stem cells that are capable of differentiation into a variety of pancreatic islet cells, including insulin-producing beta cells, as well as hepatocytes. Nestin has been identified as a molecular marker for pancreatic stem cells, while cytokeratin-19 serves as a marker for a distinct class of islet ductal cells. Methods are described whereby nestin-positive stem cells can be isolated from pancreatic islets and cultured to obtain further stem cells or pseudo-islet like structures. Methods for ex vivo differentiation of the pancreatic stem cells are disclosed. Methods are described whereby pancreatic stem cells can be isolated, expanded, and transplanted into a patient in need thereof, either allogeneically, isogeneically or xenogenically, to provide replacement for lost or damaged insulin-secreting cells or other cells.
    Type: Grant
    Filed: December 6, 2000
    Date of Patent: March 15, 2005
    Assignee: Viacell, Inc.
    Inventors: Joel F. Habener, Henryk Zulewski, Elizabeth Abraham, Mario Vallejo, Denise L. Faustman, Melissa K. Thomas
  • Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein
    Patent number: 6841386
    Abstract: The present invention features methods of modulating primary stem cell differentiation in culture by altering the endogenous activity of an insulin-like growth factor.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: January 11, 2005
    Assignee: Viacell, Inc.
    Inventors: Morey Kraus, Hongkui Deng, Liqin Liu
  • Cell population containing non-fetal hemangioblasts and method for producing same
    Patent number: 6429012
    Abstract: Methods are provided for expanding populations of non-fetal hemangioblasts, for example a method including (a) providing a first cell population containing non-fetal hemangioblasts; and (b) growing the enriched cell culture under conditions that promote the proliferation of the non-fetal hemangioblasts. Preferred populations include non-fetal uncommitted human hemangioblasts.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: August 6, 2002
    Assignee: Viacell, Inc.
    Inventors: Morey Kraus, Paul Wilder